Myanmar vs United States of America: Proportion of women aged 15-49 years with anaemia, non-pregnant
Myanmar
39.5%
in 2023
United States of America
15.1%
in 2023
Myanmar rank
29th
United States of America rank
30th
Proportion of women aged 15-49 years with anaemia, non-pregnant over time
- Myanmar
- United States of America
How they compare
Myanmar currently reports 39.5% against 15.1% in United States of America, a difference of 24.4%.
That makes Myanmar's figure about 2.6 times United States of America's.
Across all 24 years both countries report, Myanmar has been ahead every year.
Myanmar ranks 29th and United States of America ranks 30th of 209 countries.
Myanmar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Myanmar | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 40.2% | 8.1% | 32.1% | Myanmar |
| 2010s | 35.2% | 11.3% | 23.9% | Myanmar |
| 2020s | 37.8% | 14.0% | 23.8% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of women aged 15-49 years with anaemia, non-pregnant, Myanmar or United States of America?
- Myanmar, at 39.5% against 15.1% in United States of America as of 2023.
- What is the difference in proportion of women aged 15-49 years with anaemia, non-pregnant between Myanmar and United States of America?
- 24.4%, with Myanmar ahead.
- How many years of comparable data are there for Myanmar and United States of America?
- 24 years are reported by both, from 2000 to 2023.
- How do Myanmar and United States of America rank globally for proportion of women aged 15-49 years with anaemia, non-pregnant?
- Myanmar ranks 29th and United States of America ranks 30th of 209 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of women aged 15-49 years with anaemia, non-pregnant (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.